NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,396,000 | -1.0% | 713,769 | -6.5% | 3.53% | +5.8% |
| Q1 2019 | $25,650,000 | +6.9% | 763,403 | +4.5% | 3.33% | -12.9% |
| Q4 2018 | $24,003,000 | +5.7% | 730,226 | +96.0% | 3.83% | +4.4% |
| Q3 2018 | $22,711,000 | +24.3% | 372,551 | -0.5% | 3.66% | +28.8% |
| Q2 2018 | $18,275,000 | -42.7% | 374,251 | +24.7% | 2.84% | -59.4% |
| Q1 2018 | $31,887,000 | +51.8% | 300,086 | -14.7% | 7.00% | +21.6% |
| Q4 2017 | $21,006,000 | +73.9% | 351,741 | -30.1% | 5.76% | +50.6% |
| Q3 2017 | $12,077,000 | +31.4% | 503,193 | +7.0% | 3.82% | +24.0% |
| Q2 2017 | $9,192,000 | +75.3% | 470,194 | +110.5% | 3.08% | +54.0% |
| Q1 2017 | $5,244,000 | – | 223,421 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |